GlassScriptPhysician profile
Mika Jackson
NPI 1184098956
$1,943.06
in general payments reported to CMS, 2019-2025
13 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $240 · 2022: $222 · 2023: $661 · 2024: $337 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,463 · Education: $18.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,463.41 |
| Education | $18.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $416.17 | 2022-2024 | Austedo Xr, Uzedy, Austedo |
| Alkermes, INC. | $267.61 | 2021-2025 | Vivitrol |
| Novo Nordisk INC | $214.43 | 2024-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $161.67 | 2025 | Cobenfy |
| Scynexis, INC. | $130.48 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $121.87 | 2023 | Abilify Maintena, Abilify Asimtufii |
| Astellas Pharma US INC | $118.70 | 2023 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $116.78 | 2024 | Caplyta |
| Abbvie INC. | $110.29 | 2023 | |
| Horizon Therapeutics Plc | $103.80 | 2023 | Krystexxa |
| Axonics, INC. | $96.87 | 2021 | |
| Neurocrine Biosciences, INC. | $70.03 | 2025 | |
| Braeburn INC. | $14.36 | 2025 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mika Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.